Clinical Trial Update: Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 controlled study of ONO-8025 (KRP-197) for overactive bladder in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• ONO-8025 (KRP-197) (KRP-197)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED